Source: Business Wire

Press Release: Altravax : Global Equine Encephalitis Report 2016 - Therapeutics Pipeline Review of 6 Companies & Their Drug Profiles - Research and Markets

DUBLIN--(BUSINESS WIRE)--Research and Markets has announced the addition of the "Equine Encephalitis - Pipeline Review, H1 2016" report to their offering. This report provides comprehensive information on the therapeutic development for Equine Encephalitis, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It als

Read full article »
Est. Annual Revenue
$100K-5.0M
Est. Employees
1-25
Michael Chambers's photo - Interim-CEO of Altravax

Interim-CEO

Michael Chambers

CEO Approval Rating

70/100

Read more